Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

AMDE-1 is a dual function chemical for autophagy activation and inhibition

Li, M and Yang, Z and Vollmer, LL and Gao, Y and Fu, Y and Liu, C and Chen, X and Liu, P and Vogt, A and Yin, XM (2015) AMDE-1 is a dual function chemical for autophagy activation and inhibition. PLoS ONE, 10 (4).

Published Version
Available under License : See the attached license file.

Download (2MB)
[img] Plain Text (licence)
Available under License : See the attached license file.

Download (1kB)


Autophagy is the process by which cytosolic components and organelles are delivered to the lysosome for degradation. Autophagy plays important roles in cellular homeostasis and disease pathogenesis. Small chemical molecules that can modulate autophagy activity may have pharmacological value for treating diseases. Using a GFP-LC3-based high content screening assay we identified a novel chemical that is able to modulate autophagy at both initiation and degradation levels. This molecule, termed as Autophagy Modulator with Dual Effect-1 (AMDE-1), triggered autophagy in an Atg5-dependent manner, recruiting Atg16 to the pre-autophagosomal site and causing LC3 lipidation. AMDE-1 induced autophagy through the activation of AMPK, which inactivated mTORC1 and activated ULK1. AMDE-1did not affect MAP kinase, JNK or oxidative stress signaling for autophagy induction. Surprisingly, treatment with AMDE-1 resulted in impairment in autophagic flux and inhibition of long-lived protein degradation. This inhibition was correlated with a reduction in lysosomal degradation capacity but not with autophagosome-lysosome fusion. Further analysis indicated that AMDE-1 caused a reduction in lysosome acidity and lysosomal proteolytic activity, suggesting that it suppressed general lysosome function. AMDE-1 thus also impaired endocytosis-mediated EGF receptor degradation. The dual effects of AMDE-1 on autophagy induction and lysosomal degradation suggested that its net effect would likely lead to autophagic stress and lysosome dysfunction, and therefore cell death. Indeed, AMDE-1 triggered necroptosis and was preferentially cytotoxic to cancer cells. In conclusion, this study identified a new class of autophagy modulators with dual effects, which can be explored for potential uses in cancer therapy.


Social Networking:
Share |


Item Type: Article
Status: Published
CreatorsEmailPitt UsernameORCID
Li, M
Yang, Z
Vollmer, LLllv4@pitt.eduLLV4
Gao, Y
Fu, Y
Liu, C
Chen, X
Liu, P
Vogt, Aavogt@pitt.eduAVOGT
Yin, XM
ContributionContributors NameEmailPitt UsernameORCID
Centers: Other Centers, Institutes, Offices, or Units > Drug Discovery Institute
Date: 20 April 2015
Date Type: Publication
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Journal or Publication Title: PLoS ONE
Volume: 10
Number: 4
DOI or Unique Handle: 10.1371/journal.pone.0122083
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Computational and Systems Biology
Refereed: Yes
Date Deposited: 23 Aug 2016 14:04
Last Modified: 30 Mar 2021 15:55


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item